中国肿瘤整合诊治指南-肝癌(2022精简版)  

Guidelines for holistic integrative management of liver cancer(2022 abridged version)

作　　者：中国抗癌协会肝癌专业委员会 陈敏山[2] China Anti-Cancer Association Committee of Liver Cancer;Minshan Chen

机构地区：[1]不详 [2]中山大学肿瘤防治中心

出　　处：《中国肿瘤临床》2022年第17期865-873,共9页Chinese Journal of Clinical Oncology

摘　　要：肝癌是我国第5位常见恶性肿瘤及第2位肿瘤致死病因,严重威胁我国人民的生命健康。现有的国际诊疗指南在临床实践中无法兼顾我国肝癌的疾病背景、诊疗资源的地区差异、肿瘤治疗的社会价值等,难以实现个体化诊疗决策。中国抗癌协会肝癌专业委员会组织业内专家依据循证医学方法制定了《中国肿瘤整合诊治指南-肝癌》,以“防-筛-诊-治-康”为基础,内容涉及肝癌的流行病学、筛查、影像学检查、病理学评估、外科治疗、介入治疗、系统性药物治疗、放疗和中医药治疗等多学科整合治疗手段、全程康复管理等。希望本指南能够为临床医师的临床诊疗提供最佳的、有效的意见参考,从而使我国肝癌患者达到最佳的治疗效果。Liver cancer is the fifth most common malignant tumor and the second leading cause of tumor-related deaths in China,and it severely jeopardizes the health and lives of individuals.Existing guidelines for liver cancer diagnosis and treatment do not consider the disease background of liver cancer in China,regional differences in diagnosis and treatment resources,and social value of cancer treatment;therefore,achieving individualized decision-making is challenging.The General Association of the China Anti-Cancer Association organized authoritative medical oncology experts nationwide to participate in the preparation of the Guidelines for Holistic Integrative Management of Liver Cancer,which adopts the structure of“prevention-screening-diagnosis-treatment-rehabilitation”and focuses on the prevention,treatment,and rehabilitation of patients with liver cancer,including epidemiology;screening;imaging examination;pathological assessment;multidisciplinary integrated treatments,such as surgical treatment,interventional treatment,systemic drug therapy,and radiotherapy;and whole-course rehabilitation management of liver cancer.The guideline is supposed to provide the most effective references for practitioners to achieve the best outcomes for patients with liver cancer.

关 键 词：肝癌 整合诊治 指南 

分 类 号：R735.7[医药卫生—肿瘤]